R. Agbaria et al., EFFECTS OF CLONIDINE AND IBMX ON SULFOBROMOPHTHALEIN DISPOSITION IN RATS, European journal of drug metabolism and pharmacokinetics, 18(3), 1993, pp. 239-245
Clonidine, an alpha(2)-adrenoceptor agonist, inhibited the biliary exc
retion, reduced the plasma clearance and increased the hepatic retenti
on of sulfobromophthalein (BSP) in a dose related fashion in rats. The
maximal effects of clonidine on BSP disposition occurred about 4 h af
ter pretreatment. The effects of clonidine on biliary excretion and he
patic retention of BSP were retained following laparotomy (with or wit
hout bile duct cannulation); however, the effect of clonidine on plasm
a disappearance profile was not retained following abdominal surgery.
Isobutylmethylxanthine (IBMX) affected BSP disposition in a similar fa
shion as clonidine, in rats without bile duct cannulation only; no eff
ect of IBMX could be observed in bile duct cannulation rats. Yohimbine
, an alpha(2)-adrenoceptor antagonist, reversed the effects of clonidi
ne, but not of IBMX on BSP disposition. It thus seems that clonidine a
nd IBMX exert their effects on BSP disposition by different mechanisms
and probably at different sites.